Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Papular telangiectasias in hereditary haemorrhagic telangiectasia.

The British journal of dermatology·2026
Same author

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non-Syndromic Cases.

Pediatric blood & cancer·2026
Same author

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature.

Hereditary cancer in clinical practice·2026
Same author

Systematic review of cardiovascular intervention studies in women after Preeclampsia.

Pregnancy hypertension·2026
Same author

Urothelial Carcinoma of the Penile Urethra as a Potential Secondary Complication of Junctional Epidermolysis Bullosa: A Case Report and Review of the Literature.

Case reports in dermatological medicine·2026
Same author

A tale of two KRAS variants.

The British journal of dermatology·2026

Related Experiment Video

Updated: Mar 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K

Gene panel testing for hereditary breast cancer.

Ingrid Winship1, Melissa C Southey2

  • 1Office for Research, Melbourne Health, Melbourne, VIC Ingrid.Winship@mh.org.au.

The Medical Journal of Australia
|March 18, 2016
PubMed
Summary

Genetic testing for breast cancer predisposition genes beyond BRCA1/BRCA2 offers improved diagnosis. Multi-gene panel tests enhance risk assessment and management for families with hereditary breast cancer.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Related Experiment Videos

Last Updated: Mar 24, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.8K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Area of Science:

  • Genetics
  • Oncology
  • Preventive Medicine

Background:

  • Germline mutations in BRCA1 and BRCA2 genes explain only a portion of hereditary breast cancer.
  • Many families with breast cancer clustering do not harbor BRCA1/BRCA2 mutations, suggesting other genetic factors.
  • Emerging genes like PALB2 contribute to breast cancer predisposition.

Purpose of the Study:

  • To evaluate the diagnostic yield and clinical utility of multi-gene panel testing for hereditary breast cancer.
  • To explore the role of novel breast cancer predisposition genes.
  • To assess the benefits of panel testing for personalized risk management and prevention.

Main Methods:

  • Utilizing advanced genetic technology for simultaneous analysis of multiple breast cancer predisposition genes.
  • Implementing multi-gene panel testing in genetic services and familial cancer centers.
  • Comparing the diagnostic yield of panel testing versus conventional BRCA1/BRCA2 testing.

Main Results:

  • Multi-gene panel tests demonstrate a higher diagnostic yield compared to testing only BRCA1 and BRCA2.
  • Panel testing facilitates comprehensive risk assessment and personalized management strategies.
  • The clinical validity and utility of some genes on the panel require further investigation.

Conclusions:

  • Multi-gene panel testing is an effective and affordable approach for investigating hereditary breast cancer.
  • This approach enhances diagnostic capabilities, enabling better risk stratification and preventive strategies.
  • Ethical considerations, including secondary findings, must be addressed with multi-gene panel testing.